ストックスクリーナーアプリを入手
0.9926
0.73%
-0.0073
アフターアワーズ：
1.00
0.0074
+0.75%
前日終値:
$0.9999
開ける：
$1.01
24時間の取引高:
281.49K
Relative Volume:
0.42
時価総額：
$183.08M
収益：
-
当期純損益:
$52.50M
株価収益率:
34.11
EPS:
0.0291
ネットキャッシュフロー:
$-4.13M
1週間 パフォーマンス:
-8.09%
1か月 パフォーマンス:
-19.95%
6か月 パフォーマンス:
-32.48%
1年 パフォーマンス:
+76.93%
1日の値動き範囲:
$0.97
$1.025
1週間の範囲:
$0.97
$1.11
52週間の値動き範囲:
$0.2556
$3.09
Tevogen Bio Holdings Inc Stock (TVGN) Company Profile
名前
Tevogen Bio Holdings Inc
セクター
電話
646-807-8832
住所
15 INDEPENDENCE BOULEVARD, SUITE 410, WARREN
TVGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TVGN
Tevogen Bio Holdings Inc
|
0.9926 | 193.67M | 0 | 52.50M | -4.13M | 0.0291 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 118.67B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
571.54 | 59.23B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
419.56 | 52.67B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
690.32 | 41.24B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
304.30 | 32.36B | 3.81B | -644.79M | -669.77M | -6.24 |
Tevogen Bio Holdings Inc Stock (TVGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-04 | 開始されました | D. Boral Capital | Buy |
Tevogen Bio Holdings Inc (TVGN) 最新ニュース
Tevogen Bio Holdings Inc. Stock Fails to Break Resistance Traders ReactStock Portfolio Allocation Guidance for Volatile Markets - metal.it
What are Tevogen Bio Holdings Inc. Equity Warrant company’s key revenue driversRealize consistent double-digit growth - Jammu Links News
Is Tevogen Bio Holdings Inc. Equity Warrant stock overvalued or undervaluedAchieve consistent profits with proven methods - Jammu Links News
Is Tevogen Bio Holdings Inc. Equity Warrant a growth stock or a value stockExtraordinary market timing - Jammu Links News
What is the dividend policy of Tevogen Bio Holdings Inc. stockUnlock superior stock analysis tools - Jammu Links News
How many analysts rate Tevogen Bio Holdings Inc. as a “Buy”Unlock exclusive investment alerts - Jammu Links News
How does Tevogen Bio Holdings Inc. compare to its industry peersSuperior trading gains - Jammu Links News
What catalysts could drive Tevogen Bio Holdings Inc. stock higher in 2025Jaw-dropping returns - Jammu Links News
How volatile is Tevogen Bio Holdings Inc. stock compared to the marketInvest confidently with daily market forecasts - Jammu Links News
How strong is Tevogen Bio Holdings Inc. Equity Warrant company’s balance sheetUnlock exclusive stock analysis for investors - Jammu Links News
What institutional investors are buying Tevogen Bio Holdings Inc. stockOutstanding investment returns - Jammu Links News
What are analysts’ price targets for Tevogen Bio Holdings Inc. in the next 12 monthsMaximize returns with expert trading insights - Jammu Links News
Should I hold or sell Tevogen Bio Holdings Inc. stock in 2025Rapid growth trajectories - Jammu Links News
How strong is Tevogen Bio Holdings Inc. company’s balance sheetRobust investment performance - Jammu Links News
What are the technical indicators suggesting about Tevogen Bio Holdings Inc. Equity WarrantBuild a strong portfolio for growth and safety - Jammu Links News
How does Tevogen Bio Holdings Inc. Equity Warrant compare to its industry peersPhenomenal trading returns - Jammu Links News
When is Tevogen Bio Holdings Inc. stock expected to show significant growthFree Wealth Management Insights - Jammu Links News
What are Tevogen Bio Holdings Inc. company’s key revenue driversAchieve explosive financial results today - Jammu Links News
What are the technical indicators suggesting about Tevogen Bio Holdings Inc.High-margin investment plays - Jammu Links News
Published on: 2025-08-03 05:28:11 - Jammu Links News
Why is Tevogen Bio Holdings Inc. Equity Warrant stock attracting strong analyst attentionHigh-octane investment opportunities await - Jammu Links News
Does Tevogen Bio Holdings Inc. stock perform well during market downturnsUnlock powerful stock screening tools - Jammu Links News
Is Tevogen Bio Holdings Inc. Equity Warrant a good long term investmentExceptional financial outcomes - Jammu Links News
Tevogen Bio's AI-Driven Drug Discovery: A Strategic Pathway to Disrupting Biopharma and Delivering Shareholder Value - AInvest
Tevogen's AI-Driven Drug Discovery Revolution: Strategic Positioning in Biotech 2.0 and the Path to Sustainable Investor Value - AInvest
Tevogen Bio Issues Letter to Stockholders Highlighting Rapid Growth, AI Expansion, And Capital Position - 富途牛牛
Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders - GlobeNewswire
Tevogen's Major AI Push: CEO Reveals 74% Insider Stake and Microsoft Partnership in Growth Strategy - Stock Titan
Tevogen Bio shares rise 1.21% intraday after receiving $1 million grant for AI drug discovery. - AInvest
Tevogen Bio stock rises amid $1 million grant funding By Investing.com - Investing.com South Africa
Tevogen Bio stock rises amid $1 million grant funding - Investing.com
Tevogen Bio to Receive $1 Million Grant for AI Expansion, Totaling Up to $10 Million in Non-Dilutive Funding. - AInvest
Tevogen Bio to Accept $1 Million Additional Grant Funding for AI Expansion - GlobeNewswire
AI Drug Discovery Breakthrough: Tevogen Bio Receives Million-Dollar Grant to Transform Medicine Development - Stock Titan
United Therapeutics Reports Record Q2 2025 Financial Results - The Globe and Mail
Why did TVGN's Q4 2021 EPS show no surprise? - AInvest
Tevogen executives and directors own over 74% of company stock - Investing.com Australia
Tevogen executives and directors own over 74% of company stock By Investing.com - Investing.com Nigeria
Tevogen Highlights 74% Insider Ownership, Reinforcing Long-Term Vision - GlobeNewswire
Volume Profile Shows Strong Base for Tevogen Bio Holdings Inc.Weekly Watchlist of High Movers Released - metal.it
Tevogen Bio Holdings Inc. May Be Forming Higher Low — Chartwatchers AlertWatchlist for Low Risk High Return Stocks Updated - metal.it
What makes Tevogen Bio Holdings Inc. stock price move sharplyEntry Alert Based on Volume Spikes Detected - metal.it
Key External Factors That Drive Tevogen Bio Holdings Inc. Equity Warrant Stock Price MovementsNews Based Entry Opportunity Alerts Detected - metal.it
Published on: 2025-07-29 02:08:01 - metal.it
Tevogen Bio Holdings Inc. shares rise 1.85% after-hours after welcoming U.S. AI Action Plan. - AInvest
Why is Tevogen Bio Holdings Inc. stock attracting strong analyst attentionWealth Building Watchlist For Every Investor - Jammu Links News
Published on: 2025-07-28 21:09:55 - metal.it
Tevogen.AI Applauds U.S. Government's AI Action Plan; Reaffirms Commitment to Accelerating AI Innovation in Healthcare - Investing News Network
Tevogen.AI Applauds U.S. Government’s AI Action Plan; Reaffirms Commitment to Accelerating AI Innovation in Healthcare - The Globe and Mail
Tevogen.AI Applauds U.S. Government’s AI Action Plan; - GlobeNewswire
Tevogen Teams Up with Microsoft to Transform Drug Development: New AI Platform Saves Billions in Research Costs - Stock Titan
Tevogen Bio Holdings Inc (TVGN) 財務データ
収益
当期純利益
現金流量
EPS
3.24%
大文字化:
|
ボリューム (24 時間):